Although radical prostatectomy (RP) and external beam radiotherapy (EBRT) have been considered as comparable treatments for localized prostate cancer (PC), it is controversial which treatment is better. The present study aimed to compare outcomes, including mortality, of RP and EBRT for localized PC.We retrospectively analyzed 891 patients with cT1-4N0M0 PC who underwent either RP (n = 569) or EBRT (n = 322) with curative intent at our single institution between 2005 and 2012. Of the EBRT patients, 302 (93.8%) underwent intensity-modulated radiotherapy. Primary endpoints were overall survival (OS) and cancer-specific survival (CSS). Related to these, other-cause mortality (OCM) was also calculated. Biochemical recurrence-free survival was a...
Aim: To compare cancer-specific mortality (CSM) rates between radical prostatectomy (RP) vs. externa...
PurposeThe optimal treatment of clinically localized prostate cancer is controversial. Most studies ...
PurposeThe optimal treatment of clinically localized prostate cancer is controversial. Most studies ...
Although radical prostatectomy (RP) and external beam radiotherapy (EBRT) have been considered as co...
Although radical prostatectomy (RP) and external beam radiotherapy (EBRT) have been considered as co...
Background Although radical prostatectomy (RP) and external beam radiotherapy (EBRT) have been consi...
PubMedID: 30611260Background: Optimal treatment of high-risk prostate cancer remains controversial. ...
Abstract Background Optimal treatment of high-risk prostate cancer remains controversial. We aimed t...
Xiaobin Gu,1 Xianshu Gao,1 Ming Cui,1 Mu Xie,1 Mingwei Ma,1 Shangbin Qin,1 Xiaoying Li,1 Xin Qi,1 Yu...
Purpose: Our goal was to compare cancer-specific mortality (CSM) rates between radical prostatectomy...
Purpose: Our goal was to compare cancer-specific mortality (CSM) rates between radical prostatectomy...
Aim: To compare cancer-specific mortality (CSM) rates between radical prostatectomy (RP) vs. externa...
Background: We report the outcomes of a randomised trial comparing radical retropubic prostatectomy ...
Background: We report the outcomes of a randomised trial comparing radical retropubic prostatectomy ...
Background: We report the outcomes of a randomised trial comparing radical retropubic prostatectomy ...
Aim: To compare cancer-specific mortality (CSM) rates between radical prostatectomy (RP) vs. externa...
PurposeThe optimal treatment of clinically localized prostate cancer is controversial. Most studies ...
PurposeThe optimal treatment of clinically localized prostate cancer is controversial. Most studies ...
Although radical prostatectomy (RP) and external beam radiotherapy (EBRT) have been considered as co...
Although radical prostatectomy (RP) and external beam radiotherapy (EBRT) have been considered as co...
Background Although radical prostatectomy (RP) and external beam radiotherapy (EBRT) have been consi...
PubMedID: 30611260Background: Optimal treatment of high-risk prostate cancer remains controversial. ...
Abstract Background Optimal treatment of high-risk prostate cancer remains controversial. We aimed t...
Xiaobin Gu,1 Xianshu Gao,1 Ming Cui,1 Mu Xie,1 Mingwei Ma,1 Shangbin Qin,1 Xiaoying Li,1 Xin Qi,1 Yu...
Purpose: Our goal was to compare cancer-specific mortality (CSM) rates between radical prostatectomy...
Purpose: Our goal was to compare cancer-specific mortality (CSM) rates between radical prostatectomy...
Aim: To compare cancer-specific mortality (CSM) rates between radical prostatectomy (RP) vs. externa...
Background: We report the outcomes of a randomised trial comparing radical retropubic prostatectomy ...
Background: We report the outcomes of a randomised trial comparing radical retropubic prostatectomy ...
Background: We report the outcomes of a randomised trial comparing radical retropubic prostatectomy ...
Aim: To compare cancer-specific mortality (CSM) rates between radical prostatectomy (RP) vs. externa...
PurposeThe optimal treatment of clinically localized prostate cancer is controversial. Most studies ...
PurposeThe optimal treatment of clinically localized prostate cancer is controversial. Most studies ...